Risk Factors for Tumor Lysis Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With the Cyclin-Dependent Kinase Inhibitor, Flavopiridol
Leukemia - United Kingdom
doi 10.1038/leu.2011.109
Full Text
Open PDFAbstract
Available in full text
Date
May 24, 2011
Authors
Publisher
Springer Science and Business Media LLC